1. Membrane Transporter/Ion Channel Stem Cell/Wnt MAPK/ERK Pathway
  2. Piezo Channel ERK
  3. Piezo1 agonist 1-d2

Piezo1 agonist 1-d2 is a Piezo1 agonist and osteogenesis promoter with an EC50 of 2.21 μM. Piezo1 agonist 1-d2 activates Piezo1 and induces calcium ion influx in mesenchymal stem cells. Piezo1 agonist 1-d2 activates the Erk signaling pathway and promotes osteogenesis of mesenchymal stem cells. Piezo1 agonist 1-d2 alleviates disuse osteoporosis in a hindlimb unloading rat model. Piezo1 agonist 1-d2 can be used for research on osteoporosis.

For research use only. We do not sell to patients.

Piezo1 agonist 1-d<sub>2</sub>

Piezo1 agonist 1-d2 Chemical Structure

CAS No. : 3058199-62-2

Size Price Stock Quantity
1 mg Get quote 5 - 7 weeks 4 - 6 weeks 6 - 8 weeks 4 - 6 weeks
5 mg Get quote 5 - 7 weeks 4 - 6 weeks 6 - 8 weeks 4 - 6 weeks
10 mg Get quote 5 - 7 weeks 4 - 6 weeks 6 - 8 weeks 4 - 6 weeks
50 mg   Get quote  
100 mg   Get quote  
Synthetic products have potential research and development risk.

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All ERK Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Piezo1 agonist 1-d2 is a Piezo1 agonist and osteogenesis promoter with an EC50 of 2.21 μM. Piezo1 agonist 1-d2 activates Piezo1 and induces calcium ion influx in mesenchymal stem cells. Piezo1 agonist 1-d2 activates the Erk signaling pathway and promotes osteogenesis of mesenchymal stem cells. Piezo1 agonist 1-d2 alleviates disuse osteoporosis in a hindlimb unloading rat model. Piezo1 agonist 1-d2 can be used for research on osteoporosis[1].

Application

1. This compound can be used as a tracer.
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.

IC50 & Target

EC50: 2.21 μM (Piezo1)

In Vitro

Piezo1 agonist 1-d2 (compound 12a) (0.125-32 μM; 2 h) potently activates Piezo1 and induces Ca2+ influx in C3H10T1/2 mesenchymal stem cells (MSCs), with an EC50 of 2.21 μM[1].
Piezo1 agonist 1-d2 (3-5 μM; 72 h) promotes osteogenesis of bone marrow mesenchymal stem cells (BMSCs) in a dose-dependent manner, and upregulates the expression of Runx2 and Osxm RNA[1].
Piezo1 agonist 1-d2 (5 μM; 5-15 min) activates the Erk signaling pathway in BMSCs[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Real Time qPCR[1]

Cell Line: bone marrow mesenchymal stem cells (BMSCs)
Concentration: 3, 5 μM
Incubation Time: 72 h
Result: Significantly upregulated Runx2 mRNA levels at 3 μM, but did not significantly alter Osx mRNA levels.
Significantly upregulated both Runx2 mRNA levels and Osx mRNA levels at 5 μM.

Western Blot Analysis[1]

Cell Line: bone marrow mesenchymal stem cells (BMSCs)
Concentration: 5 μM
Incubation Time: 5, 10, 15 min
Result: Significantly increased p-Erk levels at 5 min.
Showed higher p-Erk/Erk ratios at 5, 10, and 15 min compared to vehicle control.
In Vivo

Piezo1 agonist 1-d2 (5 μM/kg; i.p.; 5 administrations) effectively alleviates disuse osteoporosis in hindlimb unloaded rats[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Sprague-Dawley (SD) (2 months old, hindlimb-unloading osteoporosis model)[1]
Dosage: 5 μM/kg
Administration: i.p.; 5 doses on days 1, 4, 7, 10, 13 after hindlimb unloading initiation
Result: Increased bone volume fraction (BV/TV), trabecular number (Tb.N.), and reduced trabecular separation (Tb.Sp.) compared to untreated hindlimb-unloading group.
Significantly increased Alp fluorescent area (osteogenic marker) relative to untreated hindlimb-unloading group, with osteogenesis levels nearly matching weight-bearing control rats.
Showed no significant liver or kidney toxic side effects during treatment.
Molecular Weight

430.37

Formula

C16H13D2Cl2N5OS2

CAS No.
SMILES

ClC1=C(C(Cl)=CC=C1)C([2H])(SC2=NN=C(S2)C3=CN=C(C=N3)NC[C@@H](C)O)[2H]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Piezo1 agonist 1-d2
Cat. No.:
HY-169332
Quantity:
MCE Japan Authorized Agent: